NCT00256880View on ClinicalTrials.gov

Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

December 31, 2005

Conditions
Carcinoma, Renal Cell
Interventions
DRUG

GW786034

Trial Locations (8)

3002

GSK Investigational Site, East Melbourne

3004

GSK Investigational Site, Melbourne

3050

GSK Investigational Site, Melbourne

19104

GSK Investigational Site, Philadelphia

27710

GSK Investigational Site, Durham

72205

GSK Investigational Site, Little Rock

98109

GSK Investigational Site, Seattle

02115

GSK Investigational Site, Boston

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00256880 - Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma | Biotech Hunter | Biotech Hunter